Medicare can pay for obesity drugs like Wegovy in certain heart patients
by Jonel Aleccia
Mar 21, 2024
2 minutes
Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday.
The Centers for Medicare & Medicaid Services issued new guidance that says Medicare Part D drug benefit
You’re reading a preview, subscribe to read more.
Start your free 30 days